FDA Inspection 1120528 — Shine & Pretty (USA), Corp.

Shine & Pretty (USA), Corp. — FEI 2027711

The FDA completed an inspection of Shine & Pretty (USA), Corp. on Mar 4, 2020 in Camarillo, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 4, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Camarillo, CA (United States)

Citations

IDCFRDescription
116921 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
121521 CFR 211.67(b)Written procedures not established/followed
136121 CFR 211.100(a)Absence of Written Procedures
361321 CFR 211.160(b)(4)Establishment of calibration procedures
457621 CFR 211.192No written record of investigation

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.